Logo image of BMET.CA

BEMETALS CORP (BMET.CA) Stock Fundamental Analysis

Canada - TSX-V:BMET - CA0813791096 - Common Stock

0.06 CAD
+0.01 (+20%)
Last: 9/16/2025, 7:00:00 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to BMET. BMET was compared to 807 industry peers in the Metals & Mining industry. BMET may be in some trouble as it scores bad on both profitability and health. BMET does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

BMET had negative earnings in the past year.
BMET had a negative operating cash flow in the past year.
In the past 5 years BMET always reported negative net income.
BMET had a negative operating cash flow in each of the past 5 years.
BMET.CA Yearly Net Income VS EBIT VS OCF VS FCFBMET.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M

1.2 Ratios

BMET's Return On Assets of -7.32% is fine compared to the rest of the industry. BMET outperforms 65.06% of its industry peers.
BMET has a better Return On Equity (-11.26%) than 63.82% of its industry peers.
Industry RankSector Rank
ROA -7.32%
ROE -11.26%
ROIC N/A
ROA(3y)-21.75%
ROA(5y)-16.08%
ROE(3y)-29.8%
ROE(5y)-20.92%
ROIC(3y)N/A
ROIC(5y)N/A
BMET.CA Yearly ROA, ROE, ROICBMET.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K -1K -2K -3K

1.3 Margins

BMET does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BMET.CA Yearly Profit, Operating, Gross MarginsBMET.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

1

2. Health

2.1 Basic Checks

BMET has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BMET has been increased compared to 5 years ago.
The debt/assets ratio for BMET is higher compared to a year ago.
BMET.CA Yearly Shares OutstandingBMET.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
BMET.CA Yearly Total Debt VS Total AssetsBMET.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

BMET has an Altman-Z score of -0.62. This is a bad value and indicates that BMET is not financially healthy and even has some risk of bankruptcy.
BMET has a Altman-Z score (-0.62) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.19 indicates that BMET is not too dependend on debt financing.
BMET has a worse Debt to Equity ratio (0.19) than 66.79% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Altman-Z -0.62
ROIC/WACCN/A
WACCN/A
BMET.CA Yearly LT Debt VS Equity VS FCFBMET.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

BMET has a Current Ratio of 0.26. This is a bad value and indicates that BMET is not financially healthy enough and could expect problems in meeting its short term obligations.
BMET's Current ratio of 0.26 is on the low side compared to the rest of the industry. BMET is outperformed by 75.59% of its industry peers.
BMET has a Quick Ratio of 0.26. This is a bad value and indicates that BMET is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.26, BMET is not doing good in the industry: 74.97% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.26
Quick Ratio 0.26
BMET.CA Yearly Current Assets VS Current LiabilitesBMET.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

0

3. Growth

3.1 Past

The earnings per share for BMET have decreased by -2.44% in the last year.
EPS 1Y (TTM)-2.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.46%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

BMET reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BMET.CA Price Earnings VS Forward Price EarningsBMET.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BMET.CA Per share dataBMET.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04 0.06 0.08 0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for BMET!.
Industry RankSector Rank
Dividend Yield N/A

BEMETALS CORP

TSX-V:BMET (9/16/2025, 7:00:00 PM)

0.06

+0.01 (+20%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)08-25 2025-08-25
Earnings (Next)11-24 2025-11-24
Inst Owners0.14%
Inst Owner ChangeN/A
Ins Owners14.95%
Ins Owner ChangeN/A
Market Cap13.73M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.59
P/tB 0.59
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS0.1
TBVpS0.1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.32%
ROE -11.26%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-21.75%
ROA(5y)-16.08%
ROE(3y)-29.8%
ROE(5y)-20.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.26
Quick Ratio 0.26
Altman-Z -0.62
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.46%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y13.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y31.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y21.94%
OCF growth 3YN/A
OCF growth 5YN/A